«Nevertheless,» they state, «the model provides a useful perspective on how
vaccine properties and strategic choices
affect the relative size and severity of projected epidemics,» and conclude that, «a
vaccine like the Sanofi - Pasteur candidate can be an effective tool for reducing the dengue burden, although a
vaccine with waning
efficacy would require a booster program.»